Developer docs
API playgroundTry for free, no card

Search company profiles

Li Ka Shing Foundation

Full company profile

uuid0023hl2

Namestring
Li Ka Shing Foundation
Legal namestring
Li Ka Shing Foundation Limited
Websiteurl
lksf.org
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Li Ka Shing Foundation is a private charitable foundation established in 1980 by Hong Kong entrepreneur Li Ka-shing, incorporated as Li Ka Shing Foundation Limited and headquartered at Cheung Kong Center in Central, Hong Kong. The foundation operates as a grant-making vehicle in which Mr. Li has committed one-third of his personal assets, with cumulative giving reported at over HK$30 billion on the official website (one internal source cites HK$270 billion, or USD 34.8 billion, of personal contributions). Its mission concentrates on three pillars: fostering a culture of giving, advancing education reform, and supporting healthcare development, with more than 80 percent of projects located in mainland China and Hong Kong and additional programs spanning 27 or more countries.

The foundation's core operating model is partnership-based philanthropy rather than direct service delivery. It funds and co-develops programs through institutional partners: Shantou University as the cornerstone project (HK$12 billion to date, founded 1981 as China's only privately funded public university), the Hong Kong Hospital Authority and CUHK/HKU for the 'Love Can Help' medical assistance scheme, the China Disabled Persons' Federation for the 'Cheung Kong New Milestone' disability program, and international research institutions including Oxford, Cambridge, Stanford, UC Berkeley, the University of Toronto, the University of Alberta, the University of Melbourne, and the University of Sydney. Flagship programs include the 'Human Touch of Care' (人間有情) National Hospice Care Program (32 hospice centers across 27 Chinese provinces plus 10 Hong Kong centers, serving 188,000+ terminally ill cancer patients), the 'Cheung Kong New Milestone' disability program (2+ million beneficiaries), and emergency relief initiatives such as the HK$1 billion Crunch Time Instant Relief Fund and HK$30 million for Tai Po fire-affected communities.

Revenue and distribution channels reflect the foundation's non-commercial nature. There is no pricing model, no customers, no proprietary technology product, and no commercial Go-To-Motion; resources flow as grants and co-funded research to hospitals, universities, and NGOs. The foundation communicates through its official website (lksf.org), press releases, and direct mail, and maintains a wholly owned Canadian subsidiary (Li Ka Shing (Canada) Foundation, established 2005) for jurisdiction-specific programs. It is privately controlled with no external ownership structure, and its growth is a function of Mr. Li's personal asset base and ongoing commitment, including a 2026 co-funded histotripsy clinical trial in Singapore with Temasek Trust that signals continued expansion into advanced interventional oncology.

Short descriptiontext

Li Ka Shing Foundation is a private Hong Kong charitable foundation established in 1980 by Li Ka-shing, funding healthcare, education, and anti-poverty programs through institutional partnerships across Greater China and 27+ countries, with cumulative grants exceeding HK$30 billion to date.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCentral, Hong Kong SAR China
HQ citystring
Central
HQ countrystring
Hong Kong SAR China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
charitable foundation grants, philanthropic funding programs, medical research grants, education philanthropy support, healthcare charity programs
Industry4 codes
1Education Grantmaking Foundations
CodeBPAGAKAKPrimaryYes
2Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryNo
3Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryNo
4Scholarship & Fellowship Foundations and Trusts
CodeEDADAHACPrimaryNo
NAICS code3 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
SIC code1 code
  • Services-Social Services8300
Product category
Charitable Foundation / Philanthropy
Social media profiles3 records
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Others, Personnel, Operations
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 5 records shown
1Human Touch of Care (人間有情)
Description

National Hospice Medical Service Program providing free palliative care to terminally ill cancer patients

lksf.org:443
+4 more records
Core offering1 text field

Li Ka Shing Foundation is a charitable foundation that funds education reform, medical research, healthcare access programs, and anti-poverty initiatives through grants, donations, and institutional partnerships. The cornerstone project is Shantou University (HKD 12 billion invested), complemented by a nationwide hospice care program, disability rehabilitation services, medical assistance for under-served patients, and emergency relief funding. Total grants exceed HK$30 billion to date.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 267,000+ patient service sessions for hospice care nationwide
+3 more records
Product overview1 text field

Li Ka Shing Foundation is a charitable foundation established in 1980 by entrepreneur Li Ka-shing. Rather than a commercial product company, the foundation operates as a philanthropic organization focused on three core strategic areas: fostering a culture of giving, advancing education reform, and supporting healthcare development. The foundation does not offer commercial technology products or services; instead, it funds and supports various charitable initiatives including healthcare programs, educational institutions, and community projects across education, medical services, charity, and anti-poverty programs. Total grants exceed HK$30 billion to date, with more than 80% of projects located in Mainland China and Hong Kong.

Product and service4 records
1Human Touch of Care (人間有情) National Hospice Care Program
CategoryHospice and palliative care
Description

Free palliative care, pain management, psychological counseling, and social support for terminally ill cancer patients from low-income families, delivered through hospital partnerships across mainland China and Hong Kong.

2Cheung Kong New Milestone (長江新里程) Disability Program
CategoryDisability services and rehabilitation
Description

Provides prosthetic limbs, rehabilitation services, and employment assistance to persons with disabilities in mainland China, deployed via partnership with the China Disabled Persons' Federation.

3Love Can Help (愛能助) Medical Assistance Program
CategoryMedical financial assistance
Description

Medical assistance subsidies for 'sandwich class' Hong Kong patients who fall between government assistance eligibility thresholds and need help paying for advanced medical treatments.

4Shantou University Cornerstone Initiative
CategoryHigher education funding
Description

Comprehensive university funding in Guangdong Province focused on higher education reform, with cumulative HKD 12 billion invested to date across teaching, research, and medical facilities.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Co-funder of the $12 million HALT trial for histotripsy liver cancer treatment. Temasek Trust partnered with Li Ka Shing Foundation to fund the clinical trial at Singapore General Hospital and National Cancer Centre Singapore.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Clinical trial site for the HALT histotripsy trial for liver cancer treatment, the only such trial in Southeast Asia focused on Asian patients.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Clinical trial site for the HALT histotripsy trial, addressing anatomical differences in liver and lung positioning unique to Asian populations.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2018-11-29
Description

HKD 25 million donation to establish the 'Li Ka Shing Cell and Gene Therapy Initiative' at University of Sydney for Australia's first CAR T-cell immunotherapy trial for pancreatic cancer.

5Hong Kong Hospital Authority
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2018-08-19
Description

Partnership with Hospital Authority (HA) covering 43 public hospitals and 121 outpatient clinics for the 'Love Can Help' medical assistance program targeting 'sandwich class' patients.

lksf.org
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2018-08-19
Description

HK$1 billion donation in 2005 led to the naming of HKU's medical school as 'Li Ka Shing Medical School'. Foundation continues to support HKU medical research with HKD 17.5 million in the Love Can Help II program.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2018-08-19
Description

Foundation supports CUHK medical school with HKD 17.5 million in the Love Can Help II program, supporting research and patient assistance in areas including cancer treatment, autoimmune diseases, and chronic pain management.

830+ Hospitals Nationwide (China)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2018-06-30
Description

The '人间有情' National Hospice Care Program partners with 30+ hospitals across 27 provinces in mainland China, providing free hospice care to terminally ill cancer patients.

lksf.org
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2017-09-18
Description

HKD 23 million (USD 3 million) donation to the University of Melbourne Centre for Cancer Research (UMCCR) to support precision oncology research focusing on upper gastrointestinal cancers.

10China Organ Transplantation Development Foundation
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2015-07-21
Description

Foundation supports China's organ donation system reform and transparency initiatives, working with the foundation led by former Vice Minister of Health Dr. Huang Jiefu.

lksf.org
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2013-05-03
Description

HKD 20 million (GBP 2 million) donation for the Li Ka Shing Centre for Health Information and Discovery at Oxford University, the world's largest medical big data research institute. Opened Phase 2 in May 2017.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2010-04-23
Description

CAD 28 million (HKD 214 million) donation to establish the Li Ka Shing Virology Institute at University of Alberta, in partnership with Alberta government funding of CAD 52.5 million.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2008-04-29
Description

USD 90 million donation for the Li Ka Shing Center for Learning and Knowledge at Stanford Medical School. Also supported big data research initiative with USD 3 million donation.

14Hong Kong Hospital Authority (Hospice Program)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2007-01-01
Description

Since 2007, partnership with HA to operate the '人间有情' (Caring for Life) Hong Kong Hospice Service Program, establishing 10 hospice centers in public hospitals. Total donations exceed HK$620 million for this program.

lksf.org
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2005-11-30
Description

CAD 25 million donation to establish the Li Ka Shing Knowledge Institute at St. Michael's Hospital, University of Toronto. Named 'Urban Angel' hospital serving Toronto's disadvantaged communities.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2005-06-20
Description

HKD 312 million (USD 40 million) donation to establish the Li Ka Shing Center for Biomedical and Health Sciences at UC Berkeley. Additional USD 10 million for the Li Ka Shing Genomics Engineering Center.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2005-02-25
Description

HKD 30 million (EUR 3 million) donation to support collaboration between Pasteur Institute and the Shantou University-HKU Joint Influenza Research Centre for avian flu research.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2002-05-18
Description

HKD 53 million (GBP 5.3 million) donation for cancer research center at Cambridge University, later expanded with a HKD 50 million (GBP 5 million) additional contribution for Phase 2.

19China Disabled Persons' Federation (CDPF)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2000-01-01
Description

Long-standing partnership since 1984 for the 'Cheung Kong New Milestone' program. Over HKD 400 million donated to support prosthetic services, rehabilitation, and employment assistance for disabled persons in mainland China.

lksf.org
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on1998-01-01
Description

Established China's first free hospice care center at Shantou University Medical College First Affiliated Hospital in 1998, launching the national hospice care program.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the oldest US foundations, historically focused on public health and medical research. Comparable in century-scale accumulated giving, named-university relationships, and global health grantmaking focus areas overlapping with LKSF's cancer and infectious disease work.

TypeBroad incumbent
Description

Major private foundation focused on public health, education, and urban development. Comparable in deploying founder wealth at high-discretion scale, with a similar mix of direct program operation and grantmaking to top-tier institutional partners.

TypeBroad incumbent
Description

India's largest philanthropic conglomerate, funding education, healthcare, and rural development. Comparable as an Asia-based, founder-family-controlled philanthropic vehicle with cornerstone university partnerships (Tata Institute, IISc) and a multi-decade giving history.

TypeDirect peer
Description

Singapore-based philanthropic trust co-founded by Temasek Holdings. Directly comparable as a recently-actualized co-funder of the HALT histotripsy trial with LKSF, focused on Asia-region health and education grantmaking, and similar in deploying sovereign-linked capital for social impact.

TypeDirect peer
Description

Founder-led philanthropic LLC funded by Mark Zuckerberg and Priscilla Chan. Comparable as a recently-established, founder-wealth-funded foundation with a strong focus on biomedical research (CZI Biohub) and education, and similar challenges around institutionalization beyond the founder.

TypeBroad incumbent
Description

Major US foundation focused on social justice, education, and global development. Comparable as a globally-operating grantmaking institution with diversified program areas, university partnerships, and a long track record of large-scale, multi-decade program commitments.

TypeBroad incumbent
Description

One of the world's largest charitable foundations, focused on health research with a diversified endowment model. Comparable in scale of biomedical research funding (cancer, infectious disease, genomics) and global university partnership footprint (including a major Sanger Institute investment).

TypeBroad incumbent
Description

The largest private philanthropic foundation globally, focused on global health, education, and poverty. Directly comparable as a mega-scale, family-founder-led grantmaking institution with multi-billion-dollar annual outlays and global university/hospital partnership networks.

TypeBroad incumbent
Description

France's largest philanthropic network, distributing funds across health, education, research, and social welfare. Comparable as a multi-domain grantmaking foundation with strong relationships to hospitals, universities, and NGOs across multiple countries.

TypeBroad incumbent
Description

Large US biomedical research organization operating its own research institutes and investigator programs. Comparable in its focus on fundamental medical research funding, university partnerships, and emphasis on investigator-driven science (e.g., genomics, cell biology) overlapping with LKSF's Berkeley and Stanford centers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Li Ka Shing Foundation

Charitable Foundation / Philanthropylksf.org

Li Ka Shing Foundation is a private Hong Kong charitable foundation established in 1980 by Li Ka-shing, funding healthcare, education, and anti-poverty programs through institutional partnerships across Greater China and 27+ countries, with cumulative grants exceeding HK$30 billion to date.

What Li Ka Shing Foundation does

Li Ka Shing Foundation is a private charitable foundation established in 1980 by Hong Kong entrepreneur Li Ka-shing, incorporated as Li Ka Shing Foundation Limited and headquartered at Cheung Kong Center in Central, Hong Kong. The foundation operates as a grant-making vehicle in which Mr. Li has committed one-third of his personal assets, with cumulative giving reported at over HK$30 billion on the official website (one internal source cites HK$270 billion, or USD 34.8 billion, of personal contributions). Its mission concentrates on three pillars: fostering a culture of giving, advancing education reform, and supporting healthcare development, with more than 80 percent of projects located in mainland China and Hong Kong and additional programs spanning 27 or more countries.

The foundation's core operating model is partnership-based philanthropy rather than direct service delivery. It funds and co-develops programs through institutional partners: Shantou University as the cornerstone project (HK$12 billion to date, founded 1981 as China's only privately funded public university), the Hong Kong Hospital Authority and CUHK/HKU for the 'Love Can Help' medical assistance scheme, the China Disabled Persons' Federation for the 'Cheung Kong New Milestone' disability program, and international research institutions including Oxford, Cambridge, Stanford, UC Berkeley, the University of Toronto, the University of Alberta, the University of Melbourne, and the University of Sydney. Flagship programs include the 'Human Touch of Care' (人間有情) National Hospice Care Program (32 hospice centers across 27 Chinese provinces plus 10 Hong Kong centers, serving 188,000+ terminally ill cancer patients), the 'Cheung Kong New Milestone' disability program (2+ million beneficiaries), and emergency relief initiatives such as the HK$1 billion Crunch Time Instant Relief Fund and HK$30 million for Tai Po fire-affected communities.

Revenue and distribution channels reflect the foundation's non-commercial nature. There is no pricing model, no customers, no proprietary technology product, and no commercial Go-To-Motion; resources flow as grants and co-funded research to hospitals, universities, and NGOs. The foundation communicates through its official website (lksf.org), press releases, and direct mail, and maintains a wholly owned Canadian subsidiary (Li Ka Shing (Canada) Foundation, established 2005) for jurisdiction-specific programs. It is privately controlled with no external ownership structure, and its growth is a function of Mr. Li's personal asset base and ongoing commitment, including a 2026 co-funded histotripsy clinical trial in Singapore with Temasek Trust that signals continued expansion into advanced interventional oncology.

Li Ka Shing Foundation firmographics

Firmographics
Name
Li Ka Shing Foundation
Legal name
Li Ka Shing Foundation Limited
Website
https://lksf.org
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
1–10 employees
Short description
Li Ka Shing Foundation is a private Hong Kong charitable foundation established in 1980 by Li Ka-shing, funding healthcare, education, and anti-poverty programs through institutional partnerships across Greater China and 27+ countries, with cumulative grants exceeding HK$30 billion to date.
Ownership category
akta.pro rank

Li Ka Shing Foundation industry classification

Industry
Product category
Charitable Foundation / Philanthropy
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
SIC
Services-Social Services (8300)
akta.pro primary industry
Education Grantmaking Foundations (BPAGAKAK)
akta.pro secondary industries
Health & Medical Research Grantmaking Foundations (BPAGAKAL), Research & Science Grantmaking Foundations (BPAGAKAI), Scholarship & Fellowship Foundations and Trusts (EDADAHAC)

Keywords

  • Charitable foundation grants
  • Philanthropic funding programs
  • Medical research grants
  • Education philanthropy support
  • Healthcare charity programs

Where Li Ka Shing Foundation is headquartered

Location

Headquarters

HQ city
Central
HQ country
Hong Kong SAR China
HQ region
Asia

Offices1 record

Markets served

Li Ka Shing Foundation business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Others, Personnel, Operations

Distribution channels3 records

Marketing channels3 records

Li Ka Shing Foundation product offering

Product offering

Core offering

Li Ka Shing Foundation is a charitable foundation that funds education reform, medical research, healthcare access programs, and anti-poverty initiatives through grants, donations, and institutional partnerships. The cornerstone project is Shantou University (HKD 12 billion invested), complemented by a nationwide hospice care program, disability rehabilitation services, medical assistance for under-served patients, and emergency relief funding. Total grants exceed HK$30 billion to date.

Product overview

Li Ka Shing Foundation is a charitable foundation established in 1980 by entrepreneur Li Ka-shing. Rather than a commercial product company, the foundation operates as a philanthropic organization focused on three core strategic areas: fostering a culture of giving, advancing education reform, and supporting healthcare development. The foundation does not offer commercial technology products or services; instead, it funds and supports various charitable initiatives including healthcare programs, educational institutions, and community projects across education, medical services, charity, and anti-poverty programs. Total grants exceed HK$30 billion to date, with more than 80% of projects located in Mainland China and Hong Kong.

Differentiator

Problem solved

Functional benefit

Brands

  • Human Touch of Care (人間有情): National Hospice Medical Service Program providing free palliative care to terminally ill cancer patients
  • Cheung Kong New Milestone (長江新里程)
  • Love Can Help (愛能助)
  • Crunch Time Instant Relief Fund
  • Techcracker Lab (科技夾子營)

Products and services

  • Human Touch of Care (人間有情) National Hospice Care Program Free palliative care, pain management, psychological counseling, and social support for terminally ill cancer patients from low-income families, delivered through hospital partnerships across mainland China and Hong Kong.
  • Cheung Kong New Milestone (長江新里程) Disability Program Provides prosthetic limbs, rehabilitation services, and employment assistance to persons with disabilities in mainland China, deployed via partnership with the China Disabled Persons' Federation.
  • Love Can Help (愛能助) Medical Assistance Program Medical assistance subsidies for 'sandwich class' Hong Kong patients who fall between government assistance eligibility thresholds and need help paying for advanced medical treatments.
  • Shantou University Cornerstone Initiative Comprehensive university funding in Guangdong Province focused on higher education reform, with cumulative HKD 12 billion invested to date across teaching, research, and medical facilities.

Quantifiable outcome

  • 267,000+ patient service sessions for hospice care nationwide
  • +3 more outcomes

Companies that use Li Ka Shing Foundation

Customer profile

Segments4 records

Ideal customer profiles4 records

Li Ka Shing Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Li Ka Shing Foundation partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered major and minor.

  • Temasek TrustmajorStrategic or Co-development Partner · 11 June 2026Co-funder of the $12 million HALT trial for histotripsy liver cancer treatment. Temasek Trust partnered with Li Ka Shing Foundation to fund the clinical trial at Singapore General Hospital and National Cancer Centre Singapore.
  • Singapore General HospitalmajorStrategic or Co-development Partner · 11 June 2026Clinical trial site for the HALT histotripsy trial for liver cancer treatment, the only such trial in Southeast Asia focused on Asian patients.
  • National Cancer Centre SingaporemajorStrategic or Co-development Partner · 11 June 2026Clinical trial site for the HALT histotripsy trial, addressing anatomical differences in liver and lung positioning unique to Asian populations.
  • University of SydneymajorStrategic or Co-development Partner · 29 November 2018HKD 25 million donation to establish the 'Li Ka Shing Cell and Gene Therapy Initiative' at University of Sydney for Australia's first CAR T-cell immunotherapy trial for pancreatic cancer.
  • Hong Kong Hospital AuthoritymajorStrategic or Co-development Partner · 19 August 2018Partnership with Hospital Authority (HA) covering 43 public hospitals and 121 outpatient clinics for the 'Love Can Help' medical assistance program targeting 'sandwich class' patients.
  • University of Hong Kong (HKU) Li Ka Shing Medical SchoolmajorStrategic or Co-development Partner · 19 August 2018HK$1 billion donation in 2005 led to the naming of HKU's medical school as 'Li Ka Shing Medical School'. Foundation continues to support HKU medical research with HKD 17.5 million in the Love Can Help II program.
  • Chinese University of Hong Kong (CUHK) Medical SchoolmajorStrategic or Co-development Partner · 19 August 2018Foundation supports CUHK medical school with HKD 17.5 million in the Love Can Help II program, supporting research and patient assistance in areas including cancer treatment, autoimmune diseases, and chronic pain management.
  • 30+ Hospitals Nationwide (China)majorStrategic or Co-development Partner · 30 June 2018The '人间有情' National Hospice Care Program partners with 30+ hospitals across 27 provinces in mainland China, providing free hospice care to terminally ill cancer patients.
  • University of MelbournemajorStrategic or Co-development Partner · 18 September 2017HKD 23 million (USD 3 million) donation to the University of Melbourne Centre for Cancer Research (UMCCR) to support precision oncology research focusing on upper gastrointestinal cancers.
  • China Organ Transplantation Development FoundationminorStrategic or Co-development Partner · 21 July 2015Foundation supports China's organ donation system reform and transparency initiatives, working with the foundation led by former Vice Minister of Health Dr. Huang Jiefu.
  • Oxford UniversitymajorStrategic or Co-development Partner · 3 May 2013HKD 20 million (GBP 2 million) donation for the Li Ka Shing Centre for Health Information and Discovery at Oxford University, the world's largest medical big data research institute. Opened Phase 2 in May 2017.
  • University of AlbertamajorStrategic or Co-development Partner · 23 April 2010CAD 28 million (HKD 214 million) donation to establish the Li Ka Shing Virology Institute at University of Alberta, in partnership with Alberta government funding of CAD 52.5 million.
  • Stanford UniversitymajorStrategic or Co-development Partner · 29 April 2008USD 90 million donation for the Li Ka Shing Center for Learning and Knowledge at Stanford Medical School. Also supported big data research initiative with USD 3 million donation.
  • Hong Kong Hospital Authority (Hospice Program)majorStrategic or Co-development Partner · 1 January 2007Since 2007, partnership with HA to operate the '人间有情' (Caring for Life) Hong Kong Hospice Service Program, establishing 10 hospice centers in public hospitals. Total donations exceed HK$620 million for this program.
  • St. Michael's Hospital, TorontomajorStrategic or Co-development Partner · 30 November 2005CAD 25 million donation to establish the Li Ka Shing Knowledge Institute at St. Michael's Hospital, University of Toronto. Named 'Urban Angel' hospital serving Toronto's disadvantaged communities.
  • University of California, BerkeleymajorStrategic or Co-development Partner · 20 June 2005HKD 312 million (USD 40 million) donation to establish the Li Ka Shing Center for Biomedical and Health Sciences at UC Berkeley. Additional USD 10 million for the Li Ka Shing Genomics Engineering Center.
  • Institut PasteurmajorStrategic or Co-development Partner · 25 February 2005HKD 30 million (EUR 3 million) donation to support collaboration between Pasteur Institute and the Shantou University-HKU Joint Influenza Research Centre for avian flu research.
  • Cambridge UniversitymajorStrategic or Co-development Partner · 18 May 2002HKD 53 million (GBP 5.3 million) donation for cancer research center at Cambridge University, later expanded with a HKD 50 million (GBP 5 million) additional contribution for Phase 2.
  • China Disabled Persons' Federation (CDPF)majorStrategic or Co-development Partner · 1 January 2000Long-standing partnership since 1984 for the 'Cheung Kong New Milestone' program. Over HKD 400 million donated to support prosthetic services, rehabilitation, and employment assistance for disabled persons in mainland China.
  • Shantou University Medical College First Affiliated HospitalmajorStrategic or Co-development Partner · 1 January 1998Established China's first free hospice care center at Shantou University Medical College First Affiliated Hospital in 1998, launching the national hospice care program.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Li Ka Shing Foundation competitors and assessment

Company assessment

Broad incumbents

  • Rockefeller Foundation: One of the oldest US foundations, historically focused on public health and medical research. Comparable in century-scale accumulated giving, named-university relationships, and global health grantmaking focus areas overlapping with LKSF's cancer and infectious disease work.
  • Bloomberg Philanthropies: Major private foundation focused on public health, education, and urban development. Comparable in deploying founder wealth at high-discretion scale, with a similar mix of direct program operation and grantmaking to top-tier institutional partners.
  • Tata Trusts: India's largest philanthropic conglomerate, funding education, healthcare, and rural development. Comparable as an Asia-based, founder-family-controlled philanthropic vehicle with cornerstone university partnerships (Tata Institute, IISc) and a multi-decade giving history.
  • Ford Foundation: Major US foundation focused on social justice, education, and global development. Comparable as a globally-operating grantmaking institution with diversified program areas, university partnerships, and a long track record of large-scale, multi-decade program commitments.
  • Wellcome Trust: One of the world's largest charitable foundations, focused on health research with a diversified endowment model. Comparable in scale of biomedical research funding (cancer, infectious disease, genomics) and global university partnership footprint (including a major Sanger Institute investment).
  • Bill & Melinda Gates Foundation: The largest private philanthropic foundation globally, focused on global health, education, and poverty. Directly comparable as a mega-scale, family-founder-led grantmaking institution with multi-billion-dollar annual outlays and global university/hospital partnership networks.
  • Fondation de France: France's largest philanthropic network, distributing funds across health, education, research, and social welfare. Comparable as a multi-domain grantmaking foundation with strong relationships to hospitals, universities, and NGOs across multiple countries.
  • Howard Hughes Medical Institute: Large US biomedical research organization operating its own research institutes and investigator programs. Comparable in its focus on fundamental medical research funding, university partnerships, and emphasis on investigator-driven science (e.g., genomics, cell biology) overlapping with LKSF's Berkeley and Stanford centers.

Direct peers

  • Temasek Trust: Singapore-based philanthropic trust co-founded by Temasek Holdings. Directly comparable as a recently-actualized co-funder of the HALT histotripsy trial with LKSF, focused on Asia-region health and education grantmaking, and similar in deploying sovereign-linked capital for social impact.
  • Chan Zuckerberg Initiative: Founder-led philanthropic LLC funded by Mark Zuckerberg and Priscilla Chan. Comparable as a recently-established, founder-wealth-funded foundation with a strong focus on biomedical research (CZI Biohub) and education, and similar challenges around institutionalization beyond the founder.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Li Ka Shing Foundation social profiles

Digital presence

Li Ka Shing Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Li Ka Shing Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Li Ka Shing Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Li Ka Shing Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Li Ka Shing Foundation M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Li Ka Shing Foundation

What does Li Ka Shing Foundation do?

Li Ka Shing Foundation is a charitable foundation that funds education reform, medical research, healthcare access programs, and anti-poverty initiatives through grants, donations, and institutional partnerships. The cornerstone project is Shantou University (HKD 12 billion invested), complemented by a nationwide hospice care program, disability rehabilitation services, medical assistance for under-served patients, and emergency relief funding. Total grants exceed HK$30 billion to date.

Is Li Ka Shing Foundation a public or private company?

Li Ka Shing Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Li Ka Shing Foundation founded?

Li Ka Shing Foundation was founded in 1980. It employs 1 to 10 people.

Where is Li Ka Shing Foundation based?

Li Ka Shing Foundation is headquartered in Central, Hong Kong SAR China, in the Asia region.

Who are Li Ka Shing Foundation's main competitors?

Broad incumbents on record are Rockefeller Foundation, Bloomberg Philanthropies, Tata Trusts, Ford Foundation, Wellcome Trust, Bill & Melinda Gates Foundation, Fondation de France and Howard Hughes Medical Institute. Direct peers are Temasek Trust and Chan Zuckerberg Initiative.

Does Li Ka Shing Foundation have an API?

No public API is recorded for Li Ka Shing Foundation.

What industry is Li Ka Shing Foundation in?

Li Ka Shing Foundation's product category is Charitable Foundation / Philanthropy. Its primary akta.pro industry code is BPAGAKAK, Education Grantmaking Foundations, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
South China Morning PostLi Ka Shing Foundation, Disney gift 24,000 domestic helpers Toy Story 5 ticketsThe Li Ka Shing Foundation has partnered with The Walt Disney Company to offer 24,000 foreign domestic helpers in Hong Kong free tickets to watch Toy Story 5. Registration for the tickets will open on the Klook platform at 9pm on Wednesday. This initiative represents the latest collaboration between the Hong Kong tycoon's charity foundation and Disney to support migrant workers in the city.The Straits TimesUltrasound procedure for liver cancer saves grandfather’s place on transplant waiting listMahamood Ahamed, a 69-year-old grandfather, underwent histotripsy, a non-invasive focused ultrasound procedure, on March 19 to destroy a 1.6cm cancerous liver tumour, preserving his eligibility for a liver transplant after doctors found the tumour would have disqualified him from the waiting list. The $12 million HALT trial, funded by the Li Ka Shing Foundation and Temasek Trust and conducted at Singapore General Hospital and the National Cancer Centre Singapore, has treated 10 patients as of June 11, 2026, though the procedure remains in trial phase with unproven long-term efficacy compared to surgery. The trial is the only one in Southeast Asia focused on Asian patients, addressing anatomical differences in liver and lung positioning unique to this population.The StandardHistotripsy's Zhen Xu scores double honors; Solina Chau praises 'perfect union' of tech and humanityZhen Xu, co-founder of HistoSonics and professor at the University of Michigan, received the 2026 TIME100 Health honor and the Sony Women in Technology Award for her work on Histotripsy. Solina Chau of the Li Ka Shing Foundation praised the technology's ability to liquefy diseased tissue without surgery during a speech at Tokyo University of Science.Stanford University School of EngineeringGift propels a new Stanford program designed to help entrepreneurs make an impactThe Li Ka Shing Foundation has provided a $15 million gift to Stanford University to establish the Stanford Initiative for Entrepreneurs' Resilience and Well-Being (SIER) and support bioengineering research. The initiative aims to study and promote traits that define successful entrepreneurs, particularly focusing on mental health and underrepresented groups in health science and technology.PR NewswireSaildrone conclui primeira circunavegação não tripulada na AntárticaSaildrone, Inc., a California-based ocean data company, completed the first unmanned circumnavigation of Antarctica on August 3, 2019, after a 196-day, 22,000-kilometer mission that began and ended in Bluff, New Zealand. The wind- and solar-powered autonomous surface vehicle SD 1020 survived extreme winter conditions including 15-meter waves, 80 mph winds, and sub-zero temperatures while collecting climate data in previously unmapped waters. The mission recorded evidence that the Southern Ocean released significant carbon dioxide during winter months, findings that could have important implications for global climate models, with all data freely distributed to the global scientific community.Business InsiderThe richest man in Hong Kong just pledged to cover 5 years of tuition for an entire college class, and it's going to cost him $14.4 million a year to do itLi Ka-Shing Foundation will cover tuition for Shantou University's incoming class for up to five years, costing $14.4 million annually. The 90-year-old billionaire, net worth $30.4 billion, has previously served as the school's honorary president. The initiative aims to make higher education more accessible in China.BerkeleyNew DNA-editing technology spawns bold UC initiativeThe University of California, Berkeley, and UC San Francisco have launched the Innovative Genomics Initiative (IGI), which aims to advance genetic engineering using CRISPR/Cas9 technology. The initiative has received a $10 million donation from the Li Ka Shing Foundation, along with $2 million in start-up funds from the universities, to support the research and development efforts in gene therapy and disease study. The initiative aims to leverage the CRISPR/Cas9 technology to transform genetic research and develop new therapeutic applications more efficiently.Business InsiderSite That Lets You Trade Startup Stock Takes Big InvestmentSecondMarket raised $15 million from the Li Ka Shing Foundation and Dunearn Investments (Temasek Holdings). The secondary market for startup stock has completed $150-200 million in private company transactions since April 2009, with $280 million listed for sale and over $1 billion available.